Login to Your Account

Days Ahead of PDUFA Date Gattex Wins Approval in SBS

By Jennifer Boggs
Managing Editor

Friday, December 21, 2012
It may have taken more than two decades, but NPS Pharmaceuticals Inc. is set to launch its first commercial product in the first quarter, following Friday's FDA approval of Gattex as a long-term treatment for short bowel syndrome.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription